Indication

Infantile autism

Infantile autism is a neurodevelopmental disorder of the central nervous system, historically recognized in diagnostic classifications and regulatory indications as an early-onset subtype of pervasive developmental disorder. Read more about Infantile autism

89 drugs 60 manufacturers

Advertisement

Drugs that treat it

Common Infantile autism therapies.

Showing 10–18 of 89 drugs

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
Mylan Pharmaceuticals

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
TORRENT PHARMAC

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
PATRIOT PHARMAC

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
DR.REDDY'S LAB

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
ZYDUS PHARMACEU

RISPERIDONE

ANTIPSYCHOTICS·SCHIZOPHRENIA·+3
Major Pharamceuticals
Filter & compare in the drug finder →Opens the drug finder with Infantile autism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Infantile autism.

Infantile autism is a neurodevelopmental disorder of the central nervous system, historically recognized in diagnostic classifications and regulatory indications as an early-onset subtype of pervasive developmental disorder.

Affecting young children, its defining clinical manifestations emerge before three years of age and persist throughout life.

The condition is characterized by profound impairments in reciprocal social interaction and verbal or nonverbal communication, alongside restricted, repetitive, and stereotyped patterns of behavior, interests, and activities.

Pathophysiologically, it involves altered neural connectivity, atypical synaptogenesis, and disrupted early brain development driven by complex polygenic and neurobiological mechanisms.

Personalize your experience

Follow Infantile autism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it